Clinical and molecular aspects of RAS related disorders

Area of Science:

• Molecular Biology
• Genetics
• Developmental Biology

Background:

• RAS proteins are vital for cell growth, transformation, and cognitive functions.
• Somatic mutations in RAS genes are linked to various human cancers.
• Germline mutations in RAS pathway genes cause overlapping neuro-cardio-facial-cutaneous syndromes.

Purpose of the Study:

• To highlight the critical roles of the RAS signaling pathway in human health and disease.
• To underscore the connection between RAS pathway genetics and developmental disorders.
• To emphasize the pathway's involvement in oncogenesis, cognition, growth, and development.

Main Methods:

• Review of existing literature on RAS pathway genetics.
• Analysis of clinical presentations associated with germline RAS pathway mutations.
• Comparative study of somatic and germline mutations in RAS-related genes.

Main Results:

• Germline mutations in RAS pathway genes lead to neuro-cardio-facial-cutaneous syndromes with diverse phenotypes.
• These syndromes manifest as psychomotor delay, cardiac defects, facial dysmorphism, short stature, and skin abnormalities.
• The RAS-MAPK pathway is implicated in immune modulation and vascular development, in addition to cancer and development.

Conclusions:

• The RAS signaling pathway is evolutionarily conserved and plays fundamental roles beyond oncogenesis.
• Mutations in RAS pathway genes have profound effects on neurodevelopment, growth, and organ system function.
• Understanding RAS pathway genetics is crucial for diagnosing and potentially treating a spectrum of developmental and oncological conditions.